Yuzhang Wu
About
In The Last Decade
Yuzhang Wu
320 papers receiving 9.7k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Immunology 3.5k
- Molecular Biology 3.2k
- Infectious Diseases 2.2k
- Epidemiology 1.6k
- Oncology 1.3k
Countries citing papers authored by Yuzhang Wu
This map shows the geographic impact of Yuzhang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuzhang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuzhang Wu more than expected).
Fields of papers citing papers by Yuzhang Wu
This network shows the impact of papers produced by Yuzhang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuzhang Wu. The network helps show where Yuzhang Wu may publish in the future.
Co-authorship network of co-authors of Yuzhang Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Yuzhang Wu. A scholar is included among the top collaborators of Yuzhang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuzhang Wu. Yuzhang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 2 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 1 | |
| 7 | 32 | |
| 8 | Simultaneous Detection of VEGF and CEA by Time-Resolved Chemiluminescence Enzyme-Linked Aptamer Assay | 1 |
| 9 | 39 | |
| 10 | 2 | |
| 11 | 6 | |
| 12 | 12 | |
| 13 | 39 | |
| 14 | Shugan Lipi tablet in combination with interferon-alpha and ribavirin in the treatment of chronic hepatitis C | 1 |
| 15 | Mechanisms of the MHC class I-associated presentation of exogenous CTL epitope fused with cell-penetrating peptides | 0 |
| 16 | Expression and purification of dsRed tagged OVA epitope fusion protein | 1 |
| 17 | Suppression of sinomenine on collagen--induced arthritis mouse | 1 |
| 18 | Blocking effects of anti-sense peptide of C5a on the adhesion between pulmonary vascular endothelial cell and neutrophil | 1 |
| 19 | Prediction of the Secondary Structure and B Cell Epitopes for the M Protein of SARS Coronavirus | 2 |
| 20 | Finding and identification of a novel HLA-A2-restricted CTL epitope derived from the tumor antigen MAGE-A3 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.